Clinical trial
Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®
NCT00477126 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed
Key facts
| NCT number | NCT00477126 |
|---|---|
| Title | Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® |
| Official title | Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® in Thai Healthy Volunteers |
| Lead sponsor | The HIV Netherlands Australia Thailand Research Collaboration, Other |
| Collaborators | The Government Pharmaceutical Organization |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | GPO ritonavir versus Norvir |
| Enrollment | 16 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | May 22, 2007 |
| Last update posted | Apr 5, 2012 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: